Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Central Nervous System Neoplasms 2Thrombocytopenia 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Mesothelioma, Malignant 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Laryngeal Neoplasms 1Intraocular Lymphoma 1Hypopharyngeal Neoplasms 1Hyperthermia 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma 1Brain Neoplasms 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

Carboplatin 23Cisplatin 19pembrolizumab 14Paclitaxel 13Gemcitabine 12Pemetrexed 11130-nm albumin-bound paclitaxel 9Everolimus 8Cetuximab 8Fluorouracil 7Docetaxel 6Axitinib 6Albumin-Bound Paclitaxel 6osimertinib 5durvalumab 5Sunitinib 5Radiotherapy 5Nivolumab 5Erlotinib Hydrochloride 5Cyclophosphamide 5Sorafenib 4Radiation 4Irinotecan 4Ipilimumab 4vosaroxin 3Radiotherapy, Intensity-Modulated 3Octreotide 3Bevacizumab 31-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3trifluridine tipiracil drug combination 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma × sodium thiosulfate × Clear all
NCT04541355 2024-06-28

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

University of California, San Francisco

Phase 2 Completed
16 enrolled 12 charts
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡